患者に由来するオーガノイドは,低酸素による可塑性およびフェオクロモサイトーマとパラガンリオマの治療的脆弱性を明らかにする
bioRxiv : the preprint server for biology
|September 2, 2025
まとめ
希少な神経内分泌腫瘍 (PPGL) をモデル化した患者からのオーガノイドは,低酸素が腫瘍細胞のアイデンティティにどのように影響し,これらのがんに対する有望な治療法としてアベマシクリブを特定しています.
科学分野:
- 内分泌学
- 腫瘍学
- 分子生物学
背景:
- フェオクロモサイトーマとパラガンリオマ (PPGLs) は,治療の選択肢が限られている珍しい神経内分泌腫瘍です.
- 低酸素誘導因子 (HIF) のシグナル伝達,特にHIF-2αの調節不良は一般的な要因である.
- 確固たる臨床前モデルの欠如は,PPGLの複雑性と微小環境に関する研究を妨げています.
研究 の 目的:
- PPGLの生物学をモデル化するために,患者に由来する腫瘍オーガノイド (PDO) を確立する.
- PPGLのフェノタイプに対するマイクロ環境,特に低酸素の影響を調査する.
- PPGLの新たな治療上の脆弱性を特定する.
主な方法:
- 35 PPGLの患者由来腫瘍オルガノイド (PDO) を生成した.
- ノルモキシクおよびヒポキシク条件下で栽培されたPDO.
- 51の薬剤と組み合わせを使って 薬物スクリーニングを行いました
主要な成果:
- PPGL PDOは親の腫瘍の重要な特徴を保持した.
- 低酸素はPDOの活性を高め,HIF-1α経由で不成熟のクロマフィン状態を促進した.
- 長期にわたるノルモキシアは,高リスクの神経芽細胞腫に似ている,HIF- 2α経由のハイブリッドシンパトブロスタメセンキマ同一性を誘発した.
- CDK4/ 6阻害剤であるアベマシクリブは,PDOのサブセット,特に上皮-メゼンキム移行マーカーを有する部分において有意な活性を示した.
結論:
- PPGL PDOは神経内分泌腫瘍の生物学を研究するための貴重なプラットフォームとして機能します.
- 微小環境による可塑性は,PPGLの表型に影響し,疾患の進行に影響します.
- アベマシクリブは,PPGL患者のサブセットに対する潜在的な標的療法であり,さらなる調査とバイオマーカーの開発を保証します.
関連する概念動画
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:29Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...